Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rationale for the development of an Alzheimer’s disease vaccine
Ping Kwan, Haruki Konno, Ka‐Hou Chan, et al.
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 3, pp. 645-653
Open Access | Times Cited: 25

Showing 25 citing articles:

Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2021) Vol. 72, pp. 101496-101496
Open Access | Times Cited: 219
Targeting aging and age-related diseases with vaccines
R. H. Wu, Fei Sun, Weiqi Zhang, et al.
Nature Aging (2024) Vol. 4, Iss. 4, pp. 464-482
Closed Access | Times Cited: 25
Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation
Javad Sharifi‐Rad, Simona Rapposelli, Simona Sestito, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 9, pp. 1515-1515
Open Access | Times Cited: 48
Alzheimer’s disease: a review on the current trends of the effective diagnosis and therapeutics
Aimi Syamima Abdul Manap, Reema Almadodi, Shirin Sultana, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 8
Immunotherapies for Alzheimer’s Disease—A Review
Zachary Valiukas, Ramya Ephraim, Kathy Tangalakis, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1527-1527
Open Access | Times Cited: 33
Alzheimer’s Disease Immunotherapy: Current Strategies and Future Prospects
Ali Aljassabi, Tarek Zieneldien, Janice Kim, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 3, pp. 755-772
Closed Access | Times Cited: 6
Amyloid cascade hypothesis, tau synthesis, and role of oxidative stress in AD
Jigar Vyas, Nensi Raytthatha, Bhupendra G. Prajapati
Elsevier eBooks (2024), pp. 73-92
Closed Access | Times Cited: 5
Novel Therapeutic Strategies in Alzheimer’s Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond
Giacomo Tondo, Fabiola De Marchi, Francesca Bonardi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3098-3098
Open Access | Times Cited: 5
Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
Francesca Mantile, Antonella Prisco
Biology (2020) Vol. 9, Iss. 12, pp. 425-425
Open Access | Times Cited: 38
Vaccine Based Approaches for the Prevention and Treatment of Neurological Disease
Nicholas Aderinto, Israel Charles Abraham, Gbolahan Olatunji, et al.
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Closed Access
Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
Vyronia Vassilakopoulou, Chrysoula‐Evangelia Karachaliou, Alexandra Evangelou, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1278-1278
Open Access | Times Cited: 20
Targets, trials and tribulations in Alzheimer therapeutics
Ruchita Gharat, Gargi Dixit, Mihir Khambete, et al.
European Journal of Pharmacology (2023) Vol. 962, pp. 176230-176230
Closed Access | Times Cited: 7
The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer’s disease
ChangQing Li, Xun Zhang, Yunqian Wang, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2681-2694
Closed Access | Times Cited: 2
Immunotherapy in Alzheimer’s Disease: Current Status and Future Directions
Kshitij Vashisth, Shivani Sharma, Shampa Ghosh, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S23-S39
Closed Access | Times Cited: 2
The scientific basis of rational prescribing. A guide to precision clinical pharmacology based on the WHO 6-step method
Gerard A. Rongen, Pierre Marquet, Joop van Gerven
European Journal of Clinical Pharmacology (2020) Vol. 77, Iss. 5, pp. 677-683
Open Access | Times Cited: 16
Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease
Karen Zagorski, Olga King, Armine Hovakimyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9797-9797
Open Access | Times Cited: 4
Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches
Ayomide Victor Atoki, Patrick Maduabuchi Aja, Erick Nyakundi Ondari, et al.
International Journal of Food Properties (2023) Vol. 26, Iss. 1, pp. 2091-2127
Open Access | Times Cited: 4
Active Immunotherapy for the Prevention of Alzheimer’s and Parkinson’s Disease
Madeline M. Vroom, Jean‐Cosme Dodart
Vaccines (2024) Vol. 12, Iss. 9, pp. 973-973
Open Access | Times Cited: 1
An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β1
Ge Song, Haiqiang Yang, Ning Shen, et al.
Journal of Alzheimer s Disease (2020) Vol. 77, Iss. 4, pp. 1639-1653
Closed Access | Times Cited: 10
Beneficial Effect of ACI-24 Vaccination on Aβ Plaque Pathology and Microglial Phenotypes in an Amyloidosis Mouse Model
Jasenka Rudan Njavro, Marija Vukicevic, Emma Fiorini, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 79-79
Open Access | Times Cited: 6
Comprehensive investigation of multiple targets in the development of newer drugs for the Alzheimer’s disease
P Ashwini, Subhash L. Bodhankar, Muthal Amol, et al.
Acta Pharmaceutica Sinica B (2024)
Open Access
Future Barriers and Possible Solutions with Recent Advances in Alzheimer’s Disease
Ashish Ranjan Dwivedi, Pathuri Raghuveer
(2024), pp. 413-430
Closed Access
Design, fabrication, optimization and characterization of memantine-loaded biodegradable PLGA nanoscaffolds for treatment of Alzheimer’s disease
Varsha Rani, Ruchi Chawla
Biomedical Materials (2022) Vol. 17, Iss. 6, pp. 065024-065024
Closed Access | Times Cited: 2
Therapeutische Immunisierungen gegen Tumore und neurodegenerative Erkrankungen
Verena Scheer, Mark Goldammer, Sven Flindt, et al.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2020) Vol. 63, Iss. 11, pp. 1373-1379
Closed Access | Times Cited: 2
Recent Advances in Alzheimer’s Disease Treatments with Therapeutic Antibodies to Amyloid-β
Jerry Yang, Aaron B. Bradford
Journal of Student Research (2022) Vol. 11, Iss. 3
Open Access
Page 1

Scroll to top